Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Influenza and Other Respiratory Viruses|June 10, 2026
Comparable Neutralizing Antibody Responses Following JN.1 and KP.2-Based COVID-19 Vaccination Suggest Limited Added Value of Minor Strain Updates: A Multicentre Immunogenicity StudyLena Pracher, Mastura Wahedi, Anselm Jorda, et al.
Scientific Reports|December 8, 2017
Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4Douglas G Widman, Ellen Young, Usha Nivarthi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2012
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virionsRuklanthi de Alwis, Scott A Smith, Nicholas P Olivarez, et al.
Virology|March 15, 2013
Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunityAnna P Durbin, Sandra V Mayer, Shannan L Rossi, et al.
Plos Neglected Tropical Diseases|March 13, 2023
Infection with chikungunya virus confers heterotypic cross-neutralizing antibodies and memory B-cells against other arthritogenic alphaviruses predominantly through the B domain of the E2 glycoproteinJohn M Powers, Zoe L Lyski, Whitney C Weber, et al.
Journal of Neuromuscular Diseases|September 13, 2021
Adult North Star Network (ANSN): Consensus Guideline For The Standard Of Care Of Adults With Duchenne Muscular DystrophyR Quinlivan, B Messer, P Murphy, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2014
Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunityWilliam B Messer, Ruklanthi de Alwis, Boyd L Yount, et al.
Journal of Virology|March 11, 2016
Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1William B Messer, Boyd L Yount, Scott R Royal, et al.
Nature Communications|July 23, 2020
A global lipid map defines a network essential for Zika virus replicationHans C Leier, Jules B Weinstein, Jennifer E Kyle, et al.
Vaccines|August 29, 2024
The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ<sup>®</sup>) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural InfectionWhitney C Weber, Zachary J Streblow, Craig N Kreklywich, et al.
Pageof 15